Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus

Gurpinar T., Ekerbicer N., Harzadin N. U., Barut T., Tarakci F., Tuglu M. I.

BIOTECHNIC & HISTOCHEMISTRY, vol.86, no.6, pp.373-378, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 86 Issue: 6
  • Publication Date: 2011
  • Doi Number: 10.3109/10520295.2010.506159
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.373-378
  • Keywords: apoptosis, Atorvastatin, diabetes, oxidative stress, sciatic nerve, streptozotocin, TGF-beta1, NITRIC-OXIDE SYNTHASE, CELL-DEATH, ENDOTHELIAL-CELLS, IN-VITRO, ATORVASTATIN, DYSFUNCTION, INHIBITION, NEUROPATHY, INDUCTION, NEURONS
  • Dokuz Eylül University Affiliated: Yes


Statins are lipid-lowering drugs that are widely used for treating hyperlipidemia, especially in diabetic patients. The aim of our study was to explore the effects of atorvastatin on oxidative stress and apoptosis in the sciatic nerve due to hyperglycemia. Diabetes was induced by streptozotocin. Atorvastatin was given orally for two weeks beginning from the sixth week. Microscopic examination of sciatic nerve revealed that normal tissue organization was disrupted in streptozotocin induced diabetic rats. Treatment with Atorvastatin reduced the histological damage and protected the morphological integrity of the sciatic nerve in streptozotocin induced diabetes. Increased expressions of transforming growth factor beta-1, endothelial nitric oxide synthase and TUNEL in sciatic nerve from streptozotocin induced diabetes were reduced by Atorvastatin. Atorvastatin could improve the effects of oxidative stress and apoptosis on the sciatic nerve due to diabetes.